Non-European variants of human papillomaviruses (HPVs) 16 and 18 are associated with increased risk of developing preinvasive cervical lesions ( 1 ) . In a recent article in the Journal, Xi et al. ( 2 ) showed that European and African variants of HPVs 16 and 18 were predominantly detected in white and African American women, respectively. Most importantly, they showed that infections with these variants tend to persist longer in women whose ancestry matches that of the variant's geographic origin. Race was self-reported by study participants.
Prompted by these compelling fi ndings, we used Kaplan -Meier analysis and logrank tests to assess the outcomes of prevalent and incident variant-specifi c infection with HPVs 16 and/or 18 by different racial categories among women from the Ludwig/ McGill cohort study conducted in Brazil ( 3 ). The subject's race was inferred by trained nurses during an interview. Race categories were combined for analysis as white and nonwhite, with the latter category being composed mostly of black women or women with visible AfricanBrazilian ancestry. European variants of HPVs 16 or 18 were detected in 166 women who were followed for a period of 5 years, as previously described ( 1 ) . White women had 78 (60%) of the 130 infections with European HPVs 16 and 21 (65%) of the 32 infections with European HPV 18. In addition, one white and three nonwhite women were positive for European variants of both HPV types. Prevalent and incident HPVs 16 and 18 infections cleared at comparable rates between white and nonwhite women who were infected with European variants of these two types ( P = .436, Fig. 1 ). Comparable distributions of clearance times were observed for prevalent and incident infections with HPVs 16 or 18 that were analyzed independently and compared European and non-European variants in the two racial categories des cribed above.
Our results are, however, more in line with those of Hildesheim et al. ( 4 ), who did not observe any ethnic difference between individuals with European HPV16 variants in a study conducted in Costa Rica. In that study, microsatellite markers were analyzed to determine the degree of genetic relatedness among individuals. The lack of an association between per sistence of a given variant and the racial ancestry of the host in our study and in that of Hildesheim et al. may have originated from the greater racial admixing in the two Latin American populations studied compared with that in the US population. At least for the Brazilian population, it has been shown that the physical appearance of an individual is a poor predictor of genomic African ancestry ( 5 ) . In the study of Xi et al., the analysis was limited to white and African American women, which are two visibly distinct ethnic groups in the United States.
Xi et al. provided evidence for an evolutionary process that resulted in greater adaptability of certain intratypic variants to specifi c human population groups. This process likely results from a complex interplay between multiple genetic polymorphisms in HPV and its human host, some of which may mediate mechanisms of susceptibility and immune evasion. Unfortunately, racial admixing in Brazil and in other Latin American countries may not permit ready corroboration of this phenomenon. tween whites and nonwhites in clearance rates of European variants of human papillomaviruses (HPV) 16 and 18. In contrast, our United States -based study ( 1 ) showed more rapid clearance of European variants of HPV16 and HPV18 among African American women than among white women. It is likely that the observed lack of association between viral variants and time to clearance in the Brazilian study could be attributed in part to more racial admixing in Brazil than in the United States. It is also possible that differences in the specificity of racial categories used in each study contributed to the discrepant findings.
To illustrate how racial classifi cation affects the outcome of interest, we revisited our data by including all three race categories in the Kaplan -Meier analysis. Of 594 women with HPV16 European variants who were eligible for analysis of persistence, the mean time from date of enrollment to HPV16 DNA negativity was 17.2 months (95% confi dence interval [CI] = 15.8 to 18.6) for 460 white women, 12.9 months (95% CI = 11.2 to 14.5) for 100 African American women, and 14.8 months (95% CI = 11.7 to 18.0) for 34 women classifi ed as Asian, Pacifi c Islander, American Indian, or Alaskan native. The overall likelihood of remaining positive was statistically signifi cantly higher among white women than among African American women; it was intermediate for women classifi ed as Asian, Pacifi c Islander, American Indian, or Alaskan native ( Fig. 1 ) . A similar pattern was observed for women with HPV18 European variants. Grouping women classifi ed as Asian, Pacifi c Islander, American Indian, or Alaskan native into either the white or African American category would attenuate the race-related risk difference.
The lack of association between genetic relatedness and detection of HPV16 European versus non-European variants in the Costa Rica study ( 2 ) is not surprising because the non-European HPV16 variant group in that study included both African and Asian American variants. Asian American variants of HPV16 are rela tively common in American Indian women. Moreover, a study of a panel of 10 population-specifi c alleles found that American Indians and Europeans living in Brazil had a similar ranking on a scale of African ancestry ( 3 ). The statistically signifi cant association between HPV16 variants and human leukocyte antigen (HLA) alleles found in the Costa Rica study supports our fi ndings and indicates that specifi c HLA haplotypes may be associated with inadequate immune presentation of epitopes encoded by particular HPV variants, thereby affecting their capacity to become established or to replicate.
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